Brief: Titan Pharmaceuticals Concluded Previously Released Financial Statements For Quarter Ended Sept 30, 2023 Should No Longer Be Relied Upon

Titan Pharmaceuticals

01/04/2024 23:23

April 1 (Reuters) - Titan Pharmaceuticals Inc  TTNP.O :
    * TITAN PHARMACEUTICALS - CONCLUDED PREVIOUSLY RELEASED
FINANCIAL
STATEMENTS FOR QUARTERLY PERIOD ENDED SEPT 30, 2023 SHOULD NO
LONGER BE RELIED UPON
    * TITAN PHARMACEUTICALS INC - HAS DETERMINED EXACT AMOUNT
AND FULL
EFFECT OF ERROR IN FINANCIAL STATEMENTS FOR NON-RELIANCE PERIOD
    * TITAN PHARMACEUTICALS INC - ERROR DOES NOT CHANGE CASH
POSITION
OF COMPANY AT END OF NON-RELIANCE PERIOD
    * TITAN PHARMACEUTICALS INC - EXPECTS TO REPORT AT LEAST ONE
MATERIAL WEAKNESS AS A RESULT OF ITS ANALYSIS OF CAUSE OF THESE
RESTATEMENTS
    * TITAN PHARMACEUTICALS INC - BELIEVES THAT ITS INTERNAL
CONTROL
OVER FINANCIAL REPORTING WAS NOT EFFECTIVE
    * TITAN PHARMACEUTICALS INC - ITS DISCLOSURE CONTROLS AND
PROCEDURES WERE NOT EFFECTIVE FOR NON-RELIANCE PERIOD

Source text for Eikon:  ID:n0001829126-24-002106 
Further company coverage:  TTNP.O 

 ((Reuters.Briefs@thomsonreuters.com;))